Vanadium and bone development: Putative signaling pathways

Canadian Journal of Physiology and Pharmacology

Volumn 84, Issue 7, 2006, Pages 677-686

  Barrio, D A ^a   Etcheverry, S B ^a  

^a FACULTAD DE CIENCIAS EXACTAS   (Argentina)

Author keywords

Osteoblast; Signaling pathways; Vanadium

Indexed keywords

FORSKOLIN; GLYCOGEN SYNTHASE KINASE; GROWTH FACTOR; INSULIN; MALTOL; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR; PROTEIN KINASE INHIBITOR; SOMATOMEDIN; SOMATOMEDIN C; VANADIUM;

BIOLOGICAL ACTIVITY; BONE DEVELOPMENT; BONE MINERALIZATION; CELLULAR DISTRIBUTION; CONFERENCE PAPER; DRUG BIOAVAILABILITY; DRUG EFFECT; DRUG MECHANISM; ENZYME INHIBITION; HUMAN; NONHUMAN; OSTEOBLAST; OSTEOSARCOMA; PRIORITY JOURNAL; UNSPECIFIED SIDE EFFECT;

ANIMALS; BONE DEVELOPMENT; HUMANS; OSTEOBLASTS; OSTEOGENESIS; SIGNAL TRANSDUCTION; VANADIUM COMPOUNDS;

EID: 33845443777     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y06-022     Document Type: Conference Paper

References (103)

1. Amarnani, S., Merriman, H.L., Linkhart, T.A., Baylink, D.J., and Mohan, S. 1993. Autocrine regulators of MC3T3-E1 cell proliferation. J. Bone Miner. Res. 8: 157-165.
2. Anke, M., Groppel, B., Gruhn, K., Langer, M., and Arnhold, W. 1989. The essentiality of vanadium for animals. In: Sixth International Trace Element Symposium. Edited by M. Anke, W. Baumann, H. Bräunlich, C. Brücker, B. Groppel, and M. Grün. Fredrich- Jena. Schiller Universität, Jena. pp. 17-27.
3. Barrio, D.A., Williams, P.-A.M., Cortizo, A.M., and Etcheverry, S.B. 2003. Synthesis of a new vanadyl(IV) complex with trehalose (TreVO): insulin-mimetic activities in osteoblast-like cells in culture. J. Biol. Inorg. Chem. 8: 459-468.
4. Barrio, D.A., Cattáneo, E.R., Apezteguía, M.C., and Etcheverry, S.B. 2006. Vanadyl(IV) complexes with saccharides. Bioactivity in osteoblast-like cells in culture. Can. J. Physiol. Pharmacol. 84: This issue. doi:10.1139/Y06-021.
5. Baylink, D.J., Finkelman, R.D., and Mohan, S. 1993. Growth factors to stimulate bone formation. J. Bone Miner. Res. 8(Suppl. 2): S565-S572.
6. Borgatti, P., Martelli, A.M., Bellacosa, A., Casto, R., Massari, L., Capitani, S., and Neri, L.M. 2000. Translocation of Akt/PKB to the nucleus of osteoblast-like MC3T3-E1 cells exposed to proliferative growh factors. FEBS Lett. 477: 27-32. doi:10.1016/S0014-5793(00)01758-0.
7. Bonnefont-Rousselot, D. 2004. The role of antioxidant micronutrients in the prevention of diabetic complications. Treat. Endocrinol. 3: 41-52. doi:10.2165/00024677-200403010-00005.
8. Canalis, E. 1985. Effect of sodium vanadate on deoxyribonucleic acid and protein syntheses in cultured rat calvariae. Endocrinology, 116: 855-862.
9. Chasteen, N.D., Lord, E.M., Thompson, H.J., and Grady, J.K. 1986. Vanadium complexes of transferrin and ferritin in the rat. Biochim. Biophys. Acta, 884: 84-92.
10. Chaudhary, L.R., and Avioli, L.V. 1998. Identification and activation of mitogen-activated protein (MAP) kinase in normal human osteoblastic and bone marrow stromal cells: attenuation of MAP kinase activation by cAMP, parathyroid hormone and forskolin. Mol. Cell. Biochem. 178: 59-68. doi:10.1023/A: 1006807221545.
11. Chihara, K., and Sugimoto, T. 1997. The action of GH/IGF-I/IGFBP in osteoblasts and osteoclasts. Horm. Res. 48(Suppl. 5): 45-49
12. Cobb, M.H. 1999. MAP Kinase pathways. Prog. Biophys. Mol. Biol. 71: 479-500.
13. Cortizo, A.M., and Etcheverry, S.B. 1995. Vanadium derivatives act as growth factor-mimetic compounds upon differentiation and proliferation of osteoblast-like UMR106 cells. Mol. Cell. Biochem. 145: 97-102. doi:10.1007/BF00935481.
14. Cortizo, A.M., Salice, V.C., Vescina, C.M., and Etcheverry, S.B. 1997. Proliferative and morphological changes induced by vanadium compounds on Swiss 3T3 fibroblasts. Biometals, 10: 127-133. doi:10.1023/A:1018335324447.
15. Cortizo, A.M., Caporossi, M., Lettieri, G., and Etcheverry, S.B. 2000. Vanadate-induced nitric oxide production: role in osteoblast growth and differentiation. Eur. J. Pharmacol. 400: 279-285. doi:10.1016/S0014-2999(00) 00356-3.
16. Crans, D.C. 1994. Enzyme interactions with labile oxovanadates and other oxometalates. Comm. Inorg. Chem. 16: 35-76.
17. Crans, D.C., and Tracey, A.S. 1998. The chemistry of vanadium in aqueous and nonaqueous solution. In Vanadium compounds: chemistry, biochemistry, and therapeutic applications. Edited by A.S. Tracey and D.C. Crans. Washington DC. American Chemical Society. Vol.1, pp. 2-29.
18. Dai, S., Thompson, K.H., Vera, E., and McNeill, J.H. 1994. Toxicity studies on one-year treatment of non-diabetic and streptozotocin-diabetic rats with vanadyl sulphate. Pharmacol. Toxicol. 75: 265-273.
19. Djordjevic, C., and Wampler, G.L. 1985. Antitumor activity and toxicity of peroxo heteroligand vanadates(V) in relation to biochemistry of vanadium. J. Inorg. Biochem. 25: 51-55. doi:10.1016/0162-0134(85)83007-5.
20. Domingo, J.L. 2000. What about vanadium toxicity? Mol. Cell. Biochem. 203: 185-187. doi:10.1023/A:1007067011338.
21. Domingo, J.L., Gomez, M., Sanchez, D.J., Llobet, J.M., and Keen, C.L. 1995. Toxicology of vanadium compounds in diabetic rats: the action of chelating agents on vanadium accumulation. Mol. Cell. Biochem. 153: 233-240. doi:10.1007/BF01075942.
22. D'Onofrio, F., Le, M.Q., Chiasson, J.L., and Srivastava, A.K. 1994. Activation of mitogen activated protein (MAP) kinases by vanadate is independent of insulin receptor autophosphorylation. FEBS Lett. 340: 269-275. doi:10.1016/0014-5793(94)80152-5.
23. Eldar-Finkelman, H. 2002. Glycogen synthase kinase 3: an emerging therapeutic target. Trends Mol. Med. 8: 126-132. doi:10.1016/S1471-4914(01) 02266-3.
24. Etcheverry, S.B., and Cortizo, A.M. 1998. Vanadium bioactivity on cells in culture. In Vanadium compounds: chemistry, biochemistry, and therapeutic applications. Edited by A.S. Tracey and D.C. Crans. Washington, DC. American Chemical Society, pp. 270-276.
25. Etcheverry, S.B., Apella, M.C., and Baran, E.J. 1984. A model study of the incorporation of vanadium in bone. J. Inorg. Biochem. 20: 269-274. doi:10.1016/0162-0134(84)85025-4.
26. Etcheverry, S.B., Crans, D.C., Keramidas, A.D., and Cortizo, A.M. 1997. Insulin-mimetic action of vanadium compounds on osteoblast-like cells in culture. Arch. Biochem. Biophys. 338: 7-14. doi:10.1006/abbi.1996.9778.
27. 2+/aspirin complex. J. Inorg. Biochem. 80: 169-171. doi:10.1016/S0162-0134(00)00026-X.
28. Etcheverry, S.B., Barrio, D.A., Cortizo, A.M., and Williams, P.A.M. 2002a. Three new vanadyl(IV) complexes with non-steroidal anti-inflammatory drugs (Ibuprofen, Naproxen and Tolmetin). Bioactivity on osteoblast-like cells in culture. J. Inorg. Biochem. 88: 94-100. doi:10.1016/S0162-0134(01)00368-3.
29. Etcheverry, S.B., Williams, P.A.M., Salice, V.C., Barrio, D.A., Ferrer, E.G., and Cortizo, A.M. 2002b. Biochemical properties and mechanism of action of a vanadyl(IV)-aspirin complex on bone cell lines in culture. Biometals, 15: 37-49. doi:10.1023/A:1013183910203.
30. Evangelou, A.M. 2002. Vanadium in cancer treatment. Crit. Rev. Oncol. Hematol. 42: 249-265.
31. Facchini, D.M., Yuen, V.O., Battell, M.L., McNeill, J.H., and Grynpas, M.D. 2006. The effects of vanadium treatment on bone in diabetic and non-diabetic rats. Bone, 38: 368-377. doi:10.1016/j.bone.2005.08.015.
32. Fantus, I.G., Kadota, S., Deragon, G., Foster, B., and Posner, B.I. 1989. Pervanadate [peroxide(s-) of Vanadate] mimics insulin action in rat adipocytes via activation of the insulin receptor tyrosine kinase. Biochemistry, 28: 8864-8871. doi:10.1021/bi00448a027.
33. Franceschi, R.T., and Iyer, B.S. 1992. Relationship between collagen synthesis and expression of the osteoblast phenotype in MC3T3E1 cells. J. Bone Miner. Res. 7: 235-246.
34. Goldfine, A.B., Simonson, D.C., Folli, F., Patti, M.E., and Kahn, C.R. 1995. Effects of sodium metavanadate in humans with insulin-dependent and non-insulin dependent diabetes mellitus in vivo and in vitro studies. J. Clin. Endocrinol. Metab. 80: 3311-3320. doi:10.1210/jc.80.11.3311.
35. Gurlek, A., and Kumar, R. 2001. Regulation of osteoblast growth by interactions between transforming growth factor-beta and 1alpha,25- dihydroxyvitamin D3. Crit. Rev. Eukaryot. Gene Expr. 11: 299-317.
36. Hendy, G.N., Kaji, H., Sowa, H., Lebrun, J.J., and Canaff, L. 2005. Menin and TGF-beta superfamily member signaling via the Smad pathway in pituitary, parathyroid and osteoblast. Horm. Metab. Res. 37: 375-379. doi:10.1055/s-2005- 870152.
37. Heyliger, C.E., Tahiliani, A.G., and McNeill, J.H. 1985. Effect of Vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats. Science (Washington, D.C.), 227: 1474-1477.
38. Hock, J.M., Centella, M., and Canalis, E. 1988. Insulin-like growth factor-I has independent effect on bone matrix formation and cell replication. Endocrinology, 122: 254-259.
39. Hopkins, L.L., Jr., and Tilton, B.E. 1966. Metabolism of trace amounts of vanadium 48 in rat organs and liver subcellular particles. Am. J. Physiol. 211: 169-172.
40. Ituarte, E.A., Halstead, L.R., Iida-Klein, A., Ituarte, H.G., and Hahn, T.J. 1989. Glucose transport system in UMR-106-01 osteoblastic osteosarcoma cells: regulation by insulin. Calcif. Tissue Int. 45: 27-33.
41. Janssens, K., ten Dijke, P., Janssens, S., and Van Hul, W. 2005. Transforming growth factor-beta1 to the bone. Endocr. Rev. 26: 743-774. doi:10.1210/er.2004-0001.
42. Kano, J., Sugimoto, T., Fukase, M., and Chihara, K. 1994. Direct involvement of cAMP-dependent protein kinase in the regulation of alkaline phosphatase activity by parathyroid hormone (PTH) and PTH-related peptide in osteoblastic UMR-106 cells. Biochem. Biophys. Res. Commun. 199: 271-276. doi:10.1006/bbrc.1994.1224.
43. Kato, Y., Iwamoto, M., Koike, T., and Suzuki, F. 1987. Effect of Vanadate on cartilage-matrix proteoglycan synthesis in rabbit costal chondrocyte cultures. J. Cell Biol. 104: 311-319. doi:10.1083/jcb.104.2.311.
44. Kawane, T., and Horiuchi, N. 1999. Insulin-like growth factor I suppresses parathyroid hormone (PTH)/PTH-related protein receptor expression via a mitogen-activated protein kinase pathway in UMR-106 osteoblast-like cells. Endocrinology, 140: 871-879. doi:10.1210/en.140.2.871.
45. Kelly, G.S. 2000. Insulin resistance: lifestyle and nutritional interventions. Altern. Med. Rev. 5: 109-132.
46. Kitagawa, D., Tenemura, S., Ohata, S., Shimizu, N., Seo, J., Nishitai, G., et al. 2002. Activation of extracellular signal-regulated kinase by ultraviolet is mediated through Src-dependent epidermal growth factor receptor phosphorylation. Its implication in an anti-apoptotic function. J. Biol. Chem. 277: 366-371.
47. Kozawa, O., Takatsuki, K., Kotake, K., Yoneda, M., Oiso, Y., and Saito, H. 1989. Possible involvement of protein kinase C in proliferation and differentiation of osteoblast-like cells. FEBS Lett. 243: 183-185. doi:10.1016/0014-5793(89)80126-7.
48. Krejsa, C.M., Nadler, S.G., Esseltyn, J.M., Kavanagh, T.J., Ledbetter, J.A., and Schieven, G.L. 1997. Role of oxidative stress in the action of vanadium phosphotyrosine phosphatase inhibitors. Redox independent activation of NF-kappaB. J. Biol. Chem. 272: 11541-11549.
49. Lau, K.H., Tanimoto, H., and Baylink, D.J. 1988. Vanadate stimulates bone cell proliferation and bone collagen synthesis in vitro. Endocrinology, 123: 2858-2867.
50. Leopardi, P., Villani, P., Cordelli, E., Siniscalchi, E., Veschetti, E., and Crebelli, R. 2005. Assessment of the in vivo genotoxicity of vanadate: analysis of micronuclei and DNA damage induced in mice by oral exposure. Toxicol. Lett. 158: 39-49. doi:10.1016/j.toxlet.2005.02.009.
51. Martelli, A.M., Borgatti, P., Bortul, R., Manfredini, M., Massari, L., Capitani, S., and Neri, L.M. 2000. Phosphatidylinositol 3-kinase translocates to the nucleus of osteoblast-like MC3T3-E1 cells in response to insulin-like growth factor I and platelet-derived growth factor but not to the proapoptotic cytokine tumor necrosis factor alpha. J. Bone Miner. Res. 15: 1716-1730. doi:10.1359/jbmr.2000.15.9.1716.
52. Moeller, K., and Cortesi, R. 1991. Insulin-like growth factor-I increases trabecular bone mass in ovariectomized rat. J. Bone Miner. Res. 6: S221-S225.
53. Mohan, S., and Baylink, D.J. 1991. Bone growth factors. Clin. Orthop. Relat. Res. 263: 30-48.
54. Molinuevo, M.S., Barrio, D.A., Cortizo, A.M., and Etcheverry, S.B. 2004. Antitumoral properties of two new vanadyl(IV) complexes in osteoblasts in culture: role of apoptosis and oxidative stress. Cancer Chemother. Pharmacol. 53: 163-172. doi:10.1007/s00280-003-0708-7.
55. Mongold, J.J., Cros, G.H., Vian, L., Tep, A., Ramanadham, S., Siou, G., et al. 1990. Toxicological aspects of vanadyl sulphate on diabetic rats: effects on vanadium levels and pancreatic B-cell morphology. Pharmacol. Toxicol. 67: 192-198.
56. Narda, G.E., Vega, E.D., Pedregosa, J.C., Etcheverry, S.B., and Baran, E.J. 1992. Über die wechselwirrkung des vanadyl (IV)-kations mit calcium hydroxylapatit. Z. Naturforsch. 47b: 395-398.
57. Nemsadze, O.D. 1977. Effect of the trace element vanadium on reparative regeneration of bone tissue in the mandible. Stomatologiia (Mosk.), 56: 1-5.
58. Nielsen, F.H. 1995. Vanadium in mammalian physiology and nutrition. In Metal ions in biological systems. Vanadium and its role in life. Vol. 31. Edited by H. Sigel and A. Sigel. Marcel Dekker, Inc., New York. pp. 543-573.
59. Noda, M., and Rodan, G.A. 1986. Type-beta transforming growth factor inhibits proliferation and expression of alkaline phosphatase in murine osteoblast-like cells. Biochem. Biophys. Res. Commun. 140: 56-65. doi:10.1016/0006-291X(86)91057-0.
60. Okada, T., Kawano, Y., Sakakibara, T., Hazeki, O., and Ui, M. 1994. Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. Studies with a selective inhibitor wortmannin. J. Biol. Chem. 269: 3568-3573.
61. Pandey, S.K., Chiasson, J.L., and Srivastava, A.K. 1995. Vanadium salts stimulate mitogen-activated protein (MAP) kinases and ribosomal S6 kinases. Mol. Cell. Biochem. 153: 69-78. doi:10.1007/BF01075920.
62. Pandey, S.K., Anand-Srivastava, M.B., and Srivastava, A.K. 1998. Vanadyl sulfate-stimulated glycogen synthesis is associated with activation of phosphatidylinositol 3-kinase and is independent of insulin receptor tyrosine phosphorylation. Biochemistry, 37: 7006-7014. doi:10.1021/bi9726786.
63. Partridge, N.C., Alcorn, D., Michelangeli, V.P., Ryan, G., and Martin, T.J. 1983. Morphological and biochemical characterization of four clonal osteogenic sarcoma cell lines of rat origin. Cancer Res. 43: 4308-4314.
64. Pfeilschifter, J., and Mundy, G.R. 1987. Modulation of type beta transforming growth factor activity in bone cultures by osteotropic hormones. Proc. Natl. Acad. Sci. U.S.A. 84: 2024-2028. doi:10.1073/pnas.84.7.2024.
65. Poucheret, P., Verma, S., Grynpas, M.D., and McNeill, J.H. 1998. Vanadium and diabetes. Mol. Cell. Biochem. 188: 73-80. doi:10.1023/A:1006820522587.
66. Quarles, L.D., Yohay, D.A., Lever, L.W., Caton, R., and Wenstrup, R.J. 1992. Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: An in vitro model of osteoblast development. J. Bone Miner. Res. 7: 683-692.
67. Quarles, L.D., Hartle, J.E., II, Middleton, J.P., Zhang, J., Arthur, J.M., and Raymond, J.R. 1994. Aluminium-induced DNA synthesis in osteoblasts: Mediation by a G-protein coupled cation sensing mechanism. J. Cell. Biochem. 56: 106-117. doi:10.1002/jcb.240560115.
68. Quarles, L.D., Hartle, J.E., II, Siddhanti, S.R., Guo, R., and Hinson, T.K. 1997. A distinct cation-sensing mechanism in MC3T3E1 osteoblasts functionally related to the calcium receptor. J. Bone Miner. Res. 12: 393-402. doi:10.1359/jbmr.1997.12.3.393.
69. Raisz, L.G., and Kream, B.E. 1983. Regulation of bone formation. N. Engl. J. Med. 309: 29-83.
70. Ramanadham, S., Heyliger, C., Gresser, M.J., Tracey, A.S., and McNeill, J.H. 1991. The distribution and half-life for retention of vanadium in the organs of normal and diabetic rats orally fed with vanadium(IV) and vanadium(V). Biol. Trace Elem. Res. 30: 119-124.
71. Reddy, S.V. 2004. Regulatory mechanisms operative in osteoclasts. Crit. Rev. Eukaryot. Gene Expr. 14: 255-270. doi:10.1615/CritRevEukaryotGeneExpr.v14. i4.20.
72. Rehder, D. 1995. Inorganic considerations on the function of vanadium in biological systems. In Metal ions in biological systems. Vol. 31. Edited by H. Sigel and A. Sigel. Marcel Dekker, Inc., New York. pp. 1-43.
73. Rendell, M.S., and Kirchain, W.R. 2000. Pharmacotherapy of type 2 diabetes mellitus. Ann. Pharmacother. 34: 878-895. doi:10.1345/aph.19171.
74. Sakurai, H. 2002. A new concept: the use of vanadium complexes in the treatment of diabetes mellitus. Chem. Rec. 2: 237-248. doi:10.1002/tcr.10029.
75. Setyawati, I.A., Thompson, K.H., Yuen, V.G., Sun, Y., Battell, M., Lyster, D.M., et al. 1998. Kinetic analysis and comparison of uptake, distribution, and excretion of 48V-labeled compounds in rats. J. Appl. Physiol. 84: 569-575.
76. Shechter, Y., Eldberg, G., Shisheva, A., Gefel, D., Sekar, N., Quian, S., et al. 1998. Insulin-like effects of vanadium, reviewing in vivo and in vitro studies and mechanisms of action. In Vanadium compounds: chemistry, biochemistry, and therapeutic applications. Edited by A.S. Tracey and D.C. Crans. American Chemical Society, Washington, D.C. pp. 308-315.
77. Shisheva, A., and Shechter, Y. 1992. A cytosolic protein tyrosine kinase in rat adipocytes. FEBS Lett. 300: 93-96. doi:10.1016/0014-5793(92)80171-C.
78. Shisheva, A., and Shechter, Y. 1993. Role of cytosolic tyrosine kinase in mediating insulin-like actions of vanadate in rat adipocytes. J. Biol. Chem. 268: 6463-6469.
79. Siddhanti, S.R., Hartle, J.E., II, and Quarles, L.D. 1995. Forskolin inhibits protein kinase C-induced mitogen activated protein kinase activity in MC3T3-E1 osteoblasts. Endocrinology, 136: 4834-4841. doi:10.1210/en.136.11.4834.
80. Srivastava, A.K., and Mehdi, M.Z. 2005. Insulino-mimetic and anti-diabetic effects of vanadium compounds. Diabet. Med. 22: 2-13. doi:10.1111/j.1464-5491.2004.01381.x.
81. Stankiewicz, P.J., Tracey, A.S., and Crans, D.C. 1995. Stimulation of enzyme activity by oxovanadium complexes. In Metal ions in biological systems. Vanadium and its role in life. Vol 31. Edited by H. Sigel and A. Sigel. Marcel Dekker, Inc., New York. pp. 287-324.
82. Sudo, H., Kodama, H.-A., Amagai, Y., Yamamoto, S., and Kasai, S. 1983. In vitro diferentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J. Cell Biol. 96: 191-198. doi:10.1083/jcb.96.1.191.
83. Suzuki, A., Palmer, G., Bonjour, J.P., and Caverzasio, J. 1998. Catecholamines stimulate the proliferation and alkaline phosphatase activity of MC3T3-E1 osteoblast-like cells. Bone, 23: 197-203. doi:10.1016/S8756-3282(98) 00099-4.
84. Suzuki, A., Guicheux, J., Palmer, G., Miura, Y., Oiso, Y., Bonjour, J.P., and Caverzasio, J. 2002. Evidence for a role of p38 MAP Kinase in expression of alkaline phosphatase during cell differentiation. Bone, 30: 91-98. doi:10.1016/S8756-3282(01)00660-3.
85. Swarup, G., Cohen, S., and Garbers, D.L. 1982. Inhibition of membrane phosphotyrosyl-protein phosphatase activity by vanadate. Biochem. Biophys. Res. Commun. 107: 1104-1109. doi:10.1016/0006-291X(82)90635-0.
86. Takeuchi, Y., Nakayama, K., and Matsumoto, T. 1996. Differentiation and cell surface expression of transforming growth factor-beta receptors are regulated by interaction with matrix collagen in murine osteoblastic cells. J. Biol. Chem. 271: 3938-3944.
87. Thomas, D.M., Hards, D.K., Rogers, S.D., Ng, K.W., and Best, J.D. 1996a. Insulin receptor expression in bone. J. Bone Miner. Res. 11: 1312-1320.
88. Thomas, D.M., Maher, F., Rogers, S.D., and Best, J.D. 1996b. Expression and regulation by insulin of GLUT 3 in UMR 106-01, a clonal rat osteosarcoma cell line. Biochem. Biophys. Res. Commun. 218: 789-793. doi:10.1006/bbrc.1996. 0140.
89. Thompson, K.H., Liboiron, B.D., Sun, Y., Bellman, K.D., Setyawati, I.A., Patrick, B.O., et al. 2003. Preparation and characterization of vanadyl complexes with bidentate maltol-type ligands; in vivo comparisons of anti-diabetic therapeutic potential. J. Biol. Inorg. Chem. 8: 66-74.
90. Thrailkill, K.M., Siddhanti, R.S., Fowlkes, J.L., and Quarles, D.L. 1995. Differentiation of MC3T3E1 osteoblasts is associated with temporal changes in the expression of IGF-I and IGFBPs. Bone, 17: 307-313. doi:10.1016/8756-3282(95) 00223-Z.
91. Tracey, A.S., and Gresser, M.J. 1986. Interaction of vanadate with phenol and tyrosine: implications for the effects of vanadate on systems regulated by tyrosine phosphorylation. Proc. Natl. Acad. Sci. U.S.A. 83: 609-613. doi:10.1073/pnas.83.3.609.
92. Tremollieres, F., Mohan, S., Baylink, D.-J., and Ribot, C. 1994. Autocrine regulation of cell proliferation and secretion of insulin-like growth factor I (IGF-I) in osteoblastic cell line MC3T3-E1. Ann. Endocrinol. (Paris), 55: 95-102.
93. Tsiani, E., Abdullah, N., and Fantus, I.G. 1997. Insulin-mimetic agents vanadate and pervanadate stimulate glucose but inhibit amino acid uptake. Am. J. Physiol. 272: C156-C162.
94. Uthus, E.O., and Nielsen, F.H. 1990. Effect of vanadium, iodine and their interaction on growth, blood variables, liver trace elements and thyroid status indices in rats. Magnes. Trace Elem. 9: 219-226.
95. Verheijen, M.H., and Defize, L.H. 1995. Parathyroid hormone inhibits mitogen-activated protein kinase activation in osteosarcoma cells via a protein kinase A-dependent pathway. Endocrinology, 136: 3331-3337. doi:10.1210/en.136.8. 3331.
96. Wang, Y.Z., and Bonner, J.C. 2000. Mechanism of extracellular signal-regulated kinase (ERK)-1 and ERK-2 activation by vanadium pentoxide in rat pulmonary myofibroblasts. Am. J. Respir. Cell Mol. Biol. 22: 590-596.
97. Xia, Z., Dickens, M., Raingeaud, J., Davis, R.J., and Greenberg, M.E. 1995. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science (Washington, D.C.), 270: 1326-1331.
98. Yeh, J.I., Gulve, E.A., Rameh, L., and Birnbaum, M.J. 1995. The effects of wortmannin on rat skeletal muscle. Dissociation of signaling pathways for insulin- and contraction-activated hexose transport. J. Biol. Chem. 270: 2107-2111.
99. Yeh, G.Y., Eisenberg, D.M., Kaptchuk, T.J., and Phillips, R.S. 2003. Systematic review of herbs and dietary supplements for glycemic control in diabetes. Diabetes Care, 26: 1277-1294.
100. Yuen, V.G., Orvig, C., and McNeill, J.H. 1993. Glucose-lowering effects of a new organic vanadium complex, bis(maltolato)oxovanadium(IV). Can. J. Physiol. Pharmacol. 71: 263-269.
101. Zhang, Z., Huang, C., Li, J., Leonard, S.S., Lanciotti, R., Butterworth, L., and Shi, X. 2001. Vanadate-induced cell growth regulation and the role of reactive oxygen species. Arch. Biochem. Biophys. 392: 311-320. doi:10.1006/abbi.2001.2464.
102. Zhang, S.Q., Zhong, X.Y., Lu, W.L., Zheng, L., Zhang, X., Sun, F., Fu, G.Y., and Zhang, Q. 2005. Pharmacodynamics and pharmacokinetics of the insulin-mimetic agent vanadyl acetylacetonate in non-diabetic and diabetic rats. J. Inorg. Biochem. 99: 1064-1075. doi:10.1016/j.jinorgbio.2005.01.015.
103. Zhen, X., Bonjour, J.P., and Caverzacio, J. 1997. Platelet-derived growth factor stimulates sodium-dependent Pi transport in osteoblastic cells via phospholipase Cgamma and phosphatidylinositol 3′-kinase. J. Bone Miner. Res. 12: 36-44. doi:10.1359/jbmr.1997.12.1.36.